Please use this identifier to cite or link to this item:
Title: Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications
Authors: Ashrafizadeh, M
Kumar, AP 
Aref, AR
Zarrabi, A
Mostafavi, E
Keywords: diabetes mellitus
glucose uptake
insulin resistance
lipid metabolism
Diabetes Complications
Diabetes Mellitus
Insulin Resistance
Phosphatidylinositol 3-Kinases
Issue Date: 1-Jan-2022
Publisher: Informa UK Limited
Citation: Ashrafizadeh, M, Kumar, AP, Aref, AR, Zarrabi, A, Mostafavi, E (2022-01-01). Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications. International Journal of Nanomedicine 17 : 1229-1253. ScholarBank@NUS Repository.
Abstract: Diabetes mellitus (DM) is among the chronic metabolic disorders that its incidence rate has shown an increase in developed and wealthy countries due to lifestyle and obesity. The treatment of DM has always been of interest, and significant effort has been made in this field. Exosomes belong to extracellular vesicles with nanosized features (30–150 nm) that are involved in cell-to-cell communication and preserving homeostasis. The function of exosomes is different based on their cargo, and they may contain lipids, proteins, and nucleic acids. The present review focuses on the application of exosomes in the treatment of DM; both glucose and lipid levels are significantly affected by exosomes, and these nanostructures enhance lipid metabolism and decrease its deposition. Furthermore, exosomes promote glucose metabolism and affect the level of glycolytic enzymes and glucose transporters in DM. Type I DM results from the destruction of β cells in the pancreas, and exosomes can be employed to ameliorate apoptosis and endoplasmic reticulum (ER) stress in these cells. The exosomes have dual functions in mediating insulin resistance/sensitivity, and M1 macrophage-derived exosomes inhibit insulin secretion. The exosomes may contain miRNAs, and by transferring among cells, they can regulate various molecular pathways such as AMPK, PI3K/Akt, and β-catenin to affect DM progression. Noteworthy, exosomes are present in different body fluids such as blood circulation, and they can be employed as biomarkers for the diagnosis of diabetic patients. Future studies should focus on engineering exosomes derived from sources such as mesenchymal stem cells to treat DM as a novel strategy.
Source Title: International Journal of Nanomedicine
ISSN: 1176-9114
DOI: 10.2147/IJN.S350250
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Exosomes as Promising Nanostructures in Diabetes Mellitus From Insulin Sensitivity to Ameliorating Diabetic Complications.pdf5.67 MBAdobe PDF



Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.